Literature DB >> 8822200

Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity.

L F Gulli1, K C Palmer, Y Q Chen, K B Reddy.   

Abstract

A431 cells overexpress epidermal growth factor receptors (EGF-Rs) and are inhibited by EGF. We show that treatment of A431 cells with 10 nM EGF induced a 15-fold increase in EGF-R autophosphorylation, leading to inhibition of cell proliferation and morphological features of apoptosis. However, at a lower concentration of EGF (0.01 nM), there is a 2-fold increase in EGF-R autophosphorylation and increased cell proliferation when compared to untreated cells. EGF treatment is associated with increased expression of c-myc and decreased expression of mutant p53 and p21/WAF protein. When A431 cells were simultaneously treated with 10 nM EGF and EGF-R antibody, there was a significant reduction in EGF-R autophosphorylation that was associated with increased cell proliferation. Based on these results, we postulate that overexpression of EGF-R could allow for selective growth advantage for tumor cells in the presence of normal or decreased ligand availability. However, excessive ligand binding would result in deregulated growth signaling, leading to growth inhibition and programmed cell death.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8822200

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  24 in total

1.  Cell targeting with hybrid Qβ virus-like particles displaying epidermal growth factor.

Authors:  Jonathan K Pokorski; Marisa L Hovlid; M G Finn
Journal:  Chembiochem       Date:  2011-09-29       Impact factor: 3.164

2.  CEBPD reverses RB/E2F1-mediated gene repression and participates in HMDB-induced apoptosis of cancer cells.

Authors:  Yen-Chun Pan; Chien-Feng Li; Chiung-Yuan Ko; Min-Hsiung Pan; Pei-Jung Chen; Joseph T Tseng; Wen-Chun Wu; Wen-Chang Chang; A-Mei Huang; Esta Sterneck; Ju-Ming Wang
Journal:  Clin Cancer Res       Date:  2010-10-22       Impact factor: 12.531

3.  Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases.

Authors:  M Nagane; A Levitzki; A Gazit; W K Cavenee; H J Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

4.  Phthalocyanine-peptide conjugates for epidermal growth factor receptor targeting.

Authors:  Benson G Ongarora; Krystal R Fontenot; Xiaoke Hu; Inder Sehgal; Seetharama D Satyanarayana-Jois; M Graça H Vicente
Journal:  J Med Chem       Date:  2012-04-18       Impact factor: 7.446

5.  Extracellular matrix composition determines the transcriptional response to epidermal growth factor receptor activation.

Authors:  S J Yarwood; J R Woodgett
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

6.  Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors.

Authors:  Bram Herpers; Berina Eppink; Mark I James; Carme Cortina; Adrià Cañellas-Socias; Sylvia F Boj; Xavier Hernando-Momblona; Dominik Glodzik; Rob C Roovers; Marc van de Wetering; Carina Bartelink-Clements; Vanessa Zondag-van der Zande; Jara García Mateos; Kuan Yan; Lucia Salinaro; Abdul Basmeleh; Szabolcs Fatrai; David Maussang; Jeroen J Lammerts van Bueren; Irene Chicote; Garazi Serna; Laia Cabellos; Lorena Ramírez; Paolo Nuciforo; Ramon Salazar; Cristina Santos; Alberto Villanueva; Camille Stephan-Otto Attolini; Elena Sancho; Hector G Palmer; Josep Tabernero; Michael R Stratton; John de Kruif; Ton Logtenberg; Hans Clevers; Leo S Price; Robert G J Vries; Eduard Batlle; Mark Throsby
Journal:  Nat Cancer       Date:  2022-04-25

7.  Cellular localization of the activated EGFR determines its effect on cell growth in MDA-MB-468 cells.

Authors:  Dustin C Hyatt; Brian P Ceresa
Journal:  Exp Cell Res       Date:  2008-09-11       Impact factor: 3.905

8.  LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation.

Authors:  Gal Gur; Chanan Rubin; Menachem Katz; Ido Amit; Ami Citri; Jonas Nilsson; Ninette Amariglio; Roger Henriksson; Gideon Rechavi; Håkan Hedman; Ron Wides; Yosef Yarden
Journal:  EMBO J       Date:  2004-07-29       Impact factor: 11.598

9.  Effects of epidermal growth factor and its signal transduction inhibitors on apoptosis in human colorectal cancer cells.

Authors:  Jane C J Chao; Wen Li Peng; Sheng-Hsuan Chen
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

Review 10.  SOCS proteins in regulation of receptor tyrosine kinase signaling.

Authors:  Julhash U Kazi; Nuzhat N Kabir; Amilcar Flores-Morales; Lars Rönnstrand
Journal:  Cell Mol Life Sci       Date:  2014-04-05       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.